Table 1.
Descriptive characteristics of participants in the LV-HIIE and CMIE protocol group.
| LV-HIIE | CMIE | p-value | |
|---|---|---|---|
| Participants | 14 | 13 | |
| Males | 5 | 5 | |
| Females | 9 | 8 | |
| Females with PCOS | 6 | 5 | |
| Age (years) | 30 ± 1 | 30. ± 2 | 0.96 |
| Height (cm) | 169.5 ± 2.7 | 166.4 ± 2.3 | 0.40 |
| Weight | 84.1 ± 5.1 | 83.3 ± 5.6 | 0.92 |
| BMI (kg·m−2) | 29.2 ± 1.4 | 30.0 ± 1.8 | 0.70 |
| BMI >25 kg·m−2 | 4 males 8 females | 4 males 7 females | |
| Waist to hip ratio | 0.82 ± 0.02 | 0.84 ± 0.03 | 0.85 |
| Systolic blood pressure (mm Hg) | 122 ± 3 | 117 ± 3 | 0.20 |
| Diastolic blood pressure (mm Hg) | 85 ± 3 | 78 ± 3 | 0.07 |
| Wmax (Watts) | 175 ± 19 | 170 ± 14 | 0.82 |
| Max heart rate (BPM) | 186 ± 3 | 180 ± 4 | 0.22 |
| VO2max (ml·kg−1·min−1) | 28.7 ± 2.2 | 28.8 ± 1.9 | 0.98 |
| Total exercise session work (kJ) | 147 ± 13 | 191 ± 15* | 0.04 |
| Total exercise session duration (min) | 24 | 38* | <0.01 |
| HOMA2-IR | 1.4 ± 0.1 | 1.4 ± 0.2 | 0.78 |
| Fasting glucose (mmol/l) | 4.5 ± 0.1 | 5.0 ± 0.3 | 0.12 |
| Fasting insulin (pmol/l) | 88 ± 7 | 84 ± 12 | 0.78 |
Values are mean ± SEM.
*
p < 0.05 compared to LV-HIIE. LV-HIIE, low-volume high-intensity interval exercise; CMIE, continuous moderate-intensity exercise; PCOS, polycystic ovary syndrome; HOMA2-IR, homeostatic model assessment of insulin resistance version 2. BMI: body mass index.